GLI1 and neoplasm: Overexpression of Gli1 in glioblastoma cell lines results in increased tolerance to TMZ, whereas pharmacological inhibition of Hh signaling using GANT61 and cyclopamine resensitizes cells to chemotherapy, and treatment with cyclopamine reduced tumor burden in vivo (Li et al., 2016; Wang et al., 2017).